Finzati - Logo
MLAB logo

Mesa Laboratories, Inc.

MLAB • Healthcare Equipment & Supplies
$125.16
— 0.00 (0.00%)
Current price
EarningsLatest report: Mar 31, 2026
BALANCED PROFILENeutralConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Mixed profile. The company is not automatically unattractive, but valuation, growth, or balance-sheet evidence does not yet justify a stronger signal.
Market Cap
$693.89M
Growth
14.2%
Cash Flow
5/5
Trend
Stable
Evidence
Positive revenue growth · 6.3%Positive free cash flow · 7.77Consistent free cash flow · 5/5Manageable debt level · 0.48Healthy liquidity · 1.72
Financial data as of: Mar 31, 2026, 12:00 AM UTCLast earnings update: May 27, 2026, 12:00 AM UTCLast profile update: Aug 5, 2026, 2:36 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$125.16
Change0.00%
Shares Out5.54M
Market Cap$693.89M
Enterprise Value$757.08M
52W Range55.45 - 113.99
Beta0.93
P/E103.38
P/S2.79
P/B3.73
P/FCF16.20
EV/Sales3.04

Investment DNA

How strong this company looks for long-term investors

68
out of 100
Business Quality
Margins, moat, returns
44/100
Financial Strength
Debt, cash, stability
71/100
Growth Potential
Revenue and expansion
69/100
Price Attractiveness
Cheap or expensive today
70/100
Why this score▼
Positive revenue growth · 6.3%Positive free cash flow · 7.77Consistent free cash flow · 5/5Manageable debt level · 0.48Healthy liquidity · 1.72Expensive earnings multiple · 72.64

Analyst view

Analyst sentiment and price target

MLAB
Analyst sentiment
Based on 8 analyst votes · 2026-10-20
69/100
Neutral
Bullish
3
Hold
5
Bearish
0
Price Target
2026-06-24
Low
$94.00
Mean
$94.00
Median
$94.00
High
$94.00

Company Overview

IPO: 2/29/1984
Industry: Healthcare Equipment & Supplies
P/B i: 3.73
Debt / Equity i: 0.48
Operating Margin: 7.43%
Net Margin: 2.69%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.48
Current Ratio: 1.72
Quick Ratio: 1.72
Status: Good

Insider Transactions

Recent executive and insider activity

Sakys John
Transaction: 06/22/2026
SELL
Change
-2,827
Price
$89.50
Filing
06/23/2026
Type
SELL
Archbold Brian David
Transaction: 06/22/2026
SELL
Change
-2,516
Price
$89.50
Filing
06/23/2026
Type
SELL
Crennen Lyndsey Elizabeth
Transaction: 06/22/2026
SELL
Change
-442
Price
$89.50
Filing
06/23/2026
Type
SELL